Introduction
The dopamine (DA) D 1 receptor (D 1 R) and the glutamate (Glu) NMDA receptor (NMDAR) represent two functionally and structurally diverse receptor classes. D 1 R belongs to G-protein-coupled receptor family and couples to Gαs proteins. NMDAR are ligand-gated ion channels composed of multiple subunits (NR1, NR2A-D, and NR3A-C) [1] . A remarkable property of NMDAR is its high permeability to Ca 2+ .
Alteration of NMDAR-mediated Ca
2+ influx is reported to be involved in schizophrenia and in excitotoxic neuronal death associated with brain disorders such as stroke, epilepsy, and trauma [2] . D 1 R and NMDAR are co-localized in several brain structures, including caudate-putamen, nucleus accumbens, hippocampus, and prefrontal cortex [3] [4] [5] . D 1 R and NMDAR are constitutively interacting in cells as revealed by co-immunoprecipitation and fluorescence resonance energy transfer (FRET) studies [6] . The direct physical interaction is mediated through the C terminal of the respective protein [7] . In addition to the direct interaction at the receptor level, previous studies have also shown that the downstream signal molecules mediated by D 1 R is also found to regulate NMDAR function. For instance, D 1 R stimulated protein kinase A (PKA) was demonstrated to phosphorylate the NR1 subunit of NMDAR [8] and to enhance NMDA-mediated excitability [9] . Furthermore, the activation of D 1 R was also found to enhance NMDA currents via protein kinase C (PKC)-dependent mechanisms [10] . However, the direct D 1 R-NMDAR interaction was also reported to result in the inhibition of NMDAR-mediated currents [8] , indicating that the D 1 -NMDAR interaction is rather a diverse and complex event.
D 1 R and NMDAR are presented at high concentrations in the postsynaptic density (PSD) [6] . PSD is a highly organized subcellular fraction in which NMDAR co-exists with scaffolding proteins such as PSD-95 and other signaling proteins [11] . PSD-95 comprises three primary decidual zone (PDZ) domains, a Src-homology three domain, and a domain homologous to guanylate kinase [12] . It is known that PSD-95 utilizes those domains for protein interaction to recruit signaling proteins and to mediate its assembly with other components of the PSD.
Recent information indicates that PSD-95 can regulate membrane trafficking and intracellular signaling of a number of neurotransmitter receptors including NMDA, α-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA), and 5-hydroxytryptamine 2A (5-HT 2A ) receptors via physical interactions [13] [14] [15] . As D 1 R and NMDAR are presented at high density in the PSD [6] , it is conceivable that PSD-95 may also regulate D 1 /NMDA receptor interaction. To elucidate the role of PSD-95 in D 1 R-modulated functions of the NR1a/NR2B receptor, HEK293 cells expressing D 1 R and NR1a/NR2B receptors were employed to study the role of PSD-95 in the D 1 R-modulated NR1a/NR2B receptor-mediated Ca 2+ influx. Our study demonstrated that PSD-95 was required in D 1 R modulating NR1a/NR2B receptor function, and this modulatory effect depended on PKA and PKC.
Materials and methods
Materials Fura-2 acetoxymethyl ester (Fura-2 AM) was from Molecular Probe (Eugene, OR, USA). 3-Isobutyl-1-methyl-2,6 (1H, 3H)-purinedione (IBMX) and Pluronic-127, monoclonal anti-D 1 DA receptor antibody produced in rat clone 1-1-F11 s.E6, monoclonal anti-c-myc antibody produced in mouse clone 9E10, anti-mouse IgG (whole molecule)-TRITC antibody produced in goats, anti-HA antibody produced in rabbits, leupeptin, pepstatin A, aprotinin, and phenylmethanesulfonyl fluoride (PMSF) were purchased from Sigma (St Louis, MO, USA 
R agonist R-(+)-1-phenyl-2,3,4,5-
tetrahydro-1H-3-benzazepine-7,8-diol hydrochloride (SKF38393) stimulation for an additional 10 min. The reaction was then terminated on ice by adding 100 µL 1 mol/L trichloroacetic acid. Following the addition of 20 µL 2 mol/L K 2 CO 3 , the sample was centrifuged for 5 min at 12 000×g. The supernatant was kept (diluted in 1:10) for determining cAMP content. All experiments were performed in duplicate, and each experiment was repeated at least 3 times.
Internalization assays Cells expressing D 1 -EYFP were treated either with 10 µmol/L DA or vehicle for 30 min in serum-free DMEM and then washed 3 times with ice-cold phosphate-buffered saline (PBS). The cells were fixed in 4% paraformaldehyde for 20 min at room temperature before 3 washes of PBS. The receptor internalization was then observed with a Leica SP2 confocal microscope (Leica microsystem, Heideberg, Germany). The excitation wavelength for yellow fluorescent protein (YFP) is at 514 nm.
Calcium imaging Transfected cells were incubated with Fura-2 AM (4 µmol/L with 0.025% Pluronic-127) for 45 min in extracellular solution (135 mmol/L NaCl, 5.4 mmol/L KCl, 1.8 mmol/L CaCl 2 , 10 mmol/L glucose, and 5 mmol/L HEPES (2-[4-(2-Hydroxyethyl)-1-piperazinyl]ethanesulfonic acid), pH 6.8). After 3 washes with Fura-free extracellular solution (pH 7.2), the dishes were mounted onto the stage of an Olympus BX51WI upright microscope (Tokyo, Japan). The cells were perfused continuously at a flow rate of 1.2-1.5 mL/min. Glu/ Gly were applied via a computer-controlled Y-tube (outer ϕ=100 µm) situated 80 µm above the cells. The cells were exposed to alternating 340 nm and 380 nm light every 2 s during and immediately after Glu/Gly application. The signals were acquired via a charge coupled device (CCD) camera (CoolSNAP HQ, Roper Scientific, Duluth, GA, USA). To minimize UV exposure, images were taken every 15-60 s between drug applications. Ratio images were generated with MetaFlour software from Universal Imaging (West Chester, PA, USA). Intracellular calcium concentrations were determined by the ratio of the intensity of 340/380. NMDARdependent increases in intracellular calcium were calculated by subtracting the average baseline value from the peak value obtained during Glu/Gly application.
Data analysis All data were expressed as mean±SEM. Unless otherwise indicated, the statistical significance was determined using the least significant difference (LSD) test following ANCOVA with SPSS 11.0 (SPSS, Chicago, USA). The covariate was the average baseline NMDA response before perfusion of the antipsychotic drugs. Figure 1B, lower  panel) . The mean EC 50 value of SKF38393 was 0.16 µmol/L, similar to a previous report [16] . Figure 2A , 2B. The results clearly indicated that the activation of D 1 -EYFP did not alter NR1a/NR2B-mediated Ca 2+ influx in our system. To exclude the possibility that the EYFP tag interrupts the interaction between the D 1 R and the NR1a/NR2B receptor, non-tagged D 1 R-NR1a/NR2B receptor co-transfected cells were tested. Again, the activation of D 1 R did not alter NR1a/NR2B-mediated Ca 2+ influx as well in the cells (Figure 2A, 2B, right) . Thus, it is clear that D 1 R is unable to modulate NR1a/NR2B receptor function in our in vitro co-expression system. In order to test whether the lack of D 1 R modulation on NR1a/NR2B-mediated response as described earlier was due to insufficient PKA activation by D 1 R in the system, the cell permanent PKA PKA is involved in the modulation of NR1a/NR2B receptor function by D 1 R activation The above result reveals an important role of PSD-95 involved in D 1 R-modulated NR1a/ NR2B receptor function. As we know, D 1 R activation can lead to an increase in cAMP formation and PKA activation. We next tested whether PKA is involved in D 1 R-enhanced NR1a/NR2B receptor-mediated Ca 2+ influx in the cells which were co-expressed with PSD-95. After bath application of PKA selective inhibitor H89 (5 µmol/L), NR1a/NR2B receptor-mediated Ca 2+ influx was significantly attenuated; an average 38.7%±4.1% of inhibition was observed (F 1,2 =66.40, n=13, P<0.01, compared to that in the absence of H89, Figure  5 ), indicating that NR1a/NR2B receptor-mediated Ca 2+ influx is subjected to PKA regulation. Furthermore, H89 not only completely abolished the DA-enhanced Ca 2+ influx mediated by NMDA agonists, but also resulted in an additional inhibition while DA was presented. To check if H89-mediated inhi- (B) bar graph is the summary of the results from A (n=8, from 2 independent experiments). The cell response prior to 8-Br-cAMP application was used as the control.
Results

Establishing
bition is reversible, H89-treated cells were washed out for 10 min prior to the reapplication of Glu/Gly. However, NR1a/ NR2B receptor-mediated Ca 2+ influx was unable to recover from the inhibition ( Figure 5A) .
PKC is involved in the modulation of NR1a/NR2B receptor function induced by D 1 R activation As D 1 R may also activate PKC via a phospholipase C (PLC)-mediated mechanism and NMDAR was reported to be phosphorylated by PKC, the role of PKC was explored. NR1a/NR2B receptor-mediated Ca 2+ influx was not altered by selective PKC inhibitor chelerythrine (4.0%±2.4% of inhibition, n=15, Figure 6 ). However, chelerythrine (5 µmol/L) indeed attenuated the DA-enhanced NR1a/NR2B receptor-mediated Ca 2+ influx (15.8%±3.4%, F 1,27 =24.89, n=15, P<0.01) with less potency than that of H89. Thus, it indicates that PKC also contributed to the D 1 R modulation of NR1a/NR2B receptor function.
Discussion
The present study demonstrates that in HEK293 cells co-transfected with the D 1 R and NR1a/NR2B receptor, D 1 R activation enhances NR1a/NR2B-mediated Ca 2+ influx only in the presence of PSD-95. Moreover, when PKA or PKC activity was inhibited, the D 1 R-modulated NR1a/NR2B receptor function was also significantly attenuated. To our knowledge, this is the first evidence that D 1 /NR1a/NR2B receptor interaction depends on PSD-95.
PSD-95 is a scaffold protein abundant in PSD. PSD-95 can recruit signaling proteins and mediate assembly with other components of the PSD. It is known that PSD-95 plays an important role in mediating neurotransmitter receptor functions such as NMDA and 5-HT 2A receptors [13] [14] [15] . The present result indicates that D 1 R activation fails to modulate NR1a/ NR2B receptor-mediated Ca 2+ influx unless PSD-95 is co-expressed with the D 1 R and the NR1a/NR2B receptor. Thus, it is clear that PSD-95 is required for D 1 R-modulated NR1a/NR2B receptor function. Other studies also support the important role of scaffold proteins in the regulation of NMDAR function in transfected HEK293 cells. For instance, the PKA-modulated NMDA current was significantly enhanced while the cells were co-expressed with yotiao, another scaffold protein enriched in the PSD [17] . We here found that the physical interaction between PSD-95 and D 1 R was essential for the functional expression of D 1 R-modulated NMDAR function. It appears that PSD-95 acts as a core component in recruiting D 1 R, NMDAR, and other signal transduction molecules to form a multiple protein complex that allows the interaction between D 1 R and NMDAR. Indeed, it has been suggested that PSD-95 facilitates the dynamic regulation of phosphoprotein (such as PKA or PKC) and sequentially attaches them to the substrate (for example, the receptors). In this manner, the signals can be efficiently transduced from one kinase to the next [18] . It remains unknown how D 1 R and PSD-95 interact, and furthermore, how this physical interaction regulates NR1a/NR2B receptor function.
Both PKA and PKC are found to be involved in the D 1 R modulation of NR1a/NR2B receptor function in the presence of PSD-95 in our system. Previous findings also suggested that an anchored pool of PKA was required for the augmentation of NMDAR-induced currents in HEK293 cells [17] . In neurons, the activation of the D 1 R has been shown to enhance the NMDA current via PKA-and PKC-dependent mechanisms [9, 10] . It has also been reported that PKA, but not PKC, phosphorylates NMDAR or receptor-associated proteins, thereby inducing a conformational change of the receptor [19] . It appears that the role of PKA and PKC in D 1 Rmodulated NMDAR function varied according to the cell system employed [19] . A previous report of HEK293 cells co-expressed with D 1 R and NMDAR indicated that the activation of D 1 R could lead to an inhibition of the NMDAR current [7] . It is worthy to note that the PKA and PKC inhibitors were used throughout the experiments in this study in order to exclude the potential post-translational effect of D 1 R-stimulated PKA or PKC on NMDAR function. Thus, the observed inhibitory effect of D 1 R activation on the NMDA current is more likely a result of the conformation change due to the direct physical association between the two receptors in their system. Indeed, it appears that there are two potential mechanisms for D 1 R-modulated NMDAR function. The confirmation change resulted from the physical interaction between the two receptors inhibiting the NMDAR function [7] , whereas post-translational modification such as PKA or PKC-mediated phosphorylation enhanced NMDAR function [9, 10] . The present data demonstrated that D 1 R-enhanced NR1a/NR2B Ca 2+ influx was observed only in the presence of PSD-95, which was indeed subjected to the regulation of PKA or PKC, indicating that post-translational mechanisms play an essential role in D 1 R-modulated NMDAR function.
In summary, the present results demonstrate that the D 1 R activation of NR1a/NR2B receptor function requires the presence of PSD-95. The activation of D 1 R enhances NR1a/NR2B receptor-mediated Ca 2+ influx and is dependent on PKA and PKC ( Figure 7 ). It appears that PSD-95 is a core molecule in recruiting the two receptors to form a functional complex.
